Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

CompletedOBSERVATIONAL

Enrollment

316

Participants

Timeline

Start Date

May 20, 2005

Primary Completion Date

June 17, 2010

Study Completion Date

June 30, 2015

Conditions

Breast Cancer

Interventions

OTHER

high performance liquid chromatography

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

OTHER

medical chart review

PROCEDURE

evaluation of cancer risk factors

Trial Locations (1)

Mayo Clinic Cancer Center, Rochester